Moustapha Abidali, DO
Pulmonary Disease · Upland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 13 years
- Graduated 2013
Offices
2 locations · California Pulmonary Associates Inc · 7 clinicians in this group
Hospitals listed: 559312 · Chino Valley Medical Center · Emanate Health Foothill Presbyterian Hospital · Emanate Health Inter-Community Hospital · Montclair Hospital Medical Center · San Antonio Regional Hospital · Kindred Hospital -- La Mirada. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Abidali’s office to ask if they take your plan before you enroll.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Chino Valley Medical CenterChino, CAAcute Care Hospital · Proprietary · Has an emergency departmentPart of Prime Healthcare Services, which runs 45 hospitals in 14 statesPatients rate it 2 of 5 · 61% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.258, Oct 2024 – Sep 2025
- Emanate Health Foothill Presbyterian HospitalGlendora, CAAcute Care Hospital · Voluntary non-profit - Private · No emergency departmentPart of Emanate Health, which runs 3 hospitalsPatients rate it 2 of 5 · 63% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025
- Emanate Health Inter-Community HospitalCovina, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Emanate Health, which runs 3 hospitalsPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025
- Montclair Hospital Medical CenterMontclair, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Prime Healthcare Services, which runs 45 hospitals in 14 statesPatients rate it 2 of 5 · 58% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
- San Antonio Regional HospitalUpland, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of San Antonio Regional HospitalPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
See every measure and the patient survey for Chino Valley Medical Center
Behind the star rating — Deaths: 1 better, 2 the same, 0 worse of 3 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.258 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.1) · 201 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.44 to 1.31) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 62 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.6 · 38 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 966 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,420 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,449 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.27 (0.72 to 5.83) · 106 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.29 (0.57 to 4) · 93 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.31 (0 to 1.27) · 921 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 40 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.7 · 167 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.3 · 71 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 53.4 · 160 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 296 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 43 cases | None | Jul 2023 – Jun 2025 |
What patients said (428 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 70% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 80% |
| Yes, staff "did" give patients information about help after discharge | 75% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 67% |
| Doctors "always" treated them with courtesy and respect | 76% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 64% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 77% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 61% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Emanate Health Foothill Presbyterian Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 1 better, 5 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0 to 2) · 475 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.74 to 1.58) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.2 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 43 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 108 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 295 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.7 · 64 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.7 · 1,404 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,439 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.51) · 2,452 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.57 (1.08 to 6.06) · 286 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 71 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.51 (0.83 to 4.19) · 283 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.99 (1.35 to 20.62) · 77 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.86 (1.63 to 10.08) · 56 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.97 (0.06 to 1.88) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.662 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.026 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 44 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 234 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.2 · 139 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 308 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.1 · 520 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 85 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9 to 16.2) · 293 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.2) · 174 cases | No different | Jan 2024 – Dec 2024 |
What patients said (582 patients answered, 16% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 1 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 52% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 65% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 63% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Emanate Health Inter-Community Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 2 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.4 (0.39 to 2.4) · 990 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.53 to 1.18) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.56 (145.92 to 251.21) · 69 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.9 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 99 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.8 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.1 · 279 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 665 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.3 · 389 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.1 · 3,599 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 6,844 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.42) · 6,958 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.21 (0.98 to 5.43) · 1,118 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.46 (0 to 3.08) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.05 (0.53 to 3.58) · 1,140 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.68 (1.69 to 15.67) · 450 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.07 (1.14 to 9) · 397 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.18 to 3.17) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 0.97) · 5,698 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 213 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.578 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.853 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.438 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.205 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.1 · 352 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.7 · 631 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -2 · 136 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.5 · 336 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.2 · 731 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 1,007 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.5 to 8) · 53 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (8.8 to 16.5) · 53 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.4 · 191 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.7 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 188 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.6) · 113 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 106 cases | No different | Jan 2024 – Dec 2024 |
What patients said (924 patients answered, 12% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 70% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 77% |
| Doctors "always" explained things so they could understand | 64% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 77% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 66% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Montclair Hospital Medical Center
Behind the star rating — Deaths: 1 better, 1 the same, 0 worse of 2 measures. Safety: 1 better, 3 the same, 0 worse of 4 measures. Readmissions: 0 better, 3 the same, 1 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.13) · 114 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.46 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 11.1 · 137 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 549 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,034 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,045 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (0.8 to 6.02) · 45 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.58 to 4.03) · 46 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 775 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.036 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.263 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 48 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 62.2 · 140 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 216 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 26 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.4 to 17.4) · 46 cases | No different | Jan 2022 – Dec 2024 |
What patients said (437 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 1 |
| Doctor communication | 2 |
| Communication about medicines | 1 |
| Discharge information | 1 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 67% |
| Doctors "always" communicated well | 68% |
| Staff "always" explained | 49% |
| Yes, staff "did" give patients this information | 76% |
| Yes, staff "did" give patients information about help after discharge | 70% |
| Doctors "always" explained things so they could understand | 64% |
| Doctors "always" listened carefully | 67% |
| Doctors "always" treated them with courtesy and respect | 74% |
| Patients who gave a rating of "9" or "10" (high) | 56% |
| Staff "always" explained new medications | 65% |
| Nurses "always" explained things so they could understand | 64% |
| Nurses "always" listened carefully | 60% |
| Nurses "always" treated them with courtesy and respect | 76% |
| "Always" quiet at night | 34% |
| "YES", patients would definitely recommend the hospital | 58% |
| Staff "always" explained possible side effects | 32% |
| Yes, staff "did" give patients information about possible symptoms | 81% |
See every measure and the patient survey for San Antonio Regional Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.42 (0.49 to 2.35) · 1,107 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.12 (0.8 to 1.44) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.04 (110.22 to 223.86) · 62 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.4 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 305 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.7 · 499 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 16.7 · 398 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5 · 3,795 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 5,607 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 5,828 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.55 (3.37 to 7.73) · 1,096 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.31 (0 to 2.85) · 315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.27 to 4.28) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 15.26 (8.83 to 21.68) · 347 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.6 (0.86 to 8.34) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.05) · 331 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.35 (0 to 1.03) · 4,715 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 37 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.9 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.73 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.873 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 405 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.2 · 820 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.2 · 177 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 11 · 349 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.5 · 536 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 970 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 35 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.2 · 106 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 179 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12 (9 to 16.1) · 285 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 234 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,938 patients answered, 16% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 51% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 36% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$496,962
Medicare paid this office $496,962 for 1,010 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 307 | $152,925 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 513 | $101,333 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 549 | $98,117 | $87 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 294 | $29,802 | $95 |
| Return visit (30+ min) | 114 | $23,543 | $101 |
See all 27 services
| Critical care, first 30-74 minutes | 307 | $152,925 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 513 | $101,333 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 549 | $98,117 | $87 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 294 | $29,802 | $95 |
| Return visit (30+ min) | 114 | $23,543 | $101 |
| Advance care planning, first 30 minutes | 354 | $21,121 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 114 | $14,687 | $126 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 43 | $7,004 | $81 |
| New patient visit (45+ min) | 45 | $5,894 | $131 |
| Test to examine how well the lungs exchange gases | 92 | $4,600 | $48 |
| Test to determine lung volumes using sensors | 92 | $4,380 | $46 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 25 | $3,893 | $57 |
| Short return visit (20+ min) | 35 | $3,644 | $74 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 92 | $3,283 | $34 |
| Evaluation of use of breathing device | 90 | $2,449 | $15 |
| Test for exercise-induced lung stress | 81 | $2,406 | $29 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 25 | $2,351 | $94 |
| Long return visit (40+ min) | 13 | $2,140 | $153 |
| Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | 93 | $1,877 | $19 |
| Test to measure largest amount of air breathed in an out | 91 | $1,245 | $13 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 11 | $1,113 | $101 |
| Test to measure expiratory airflow and volume | 42 | $1,000 | $20 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 14 | $972 | $61 |
| Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 14 | $620 | $44 |
| Ct scan of chest without contrast | 11 | $462 | $42 |
| Hemoglobin measurement | 88 | $453 | $5 |
| Ultrasonic guidance for blood vessel access | 14 | $161 | $10 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Diagnostic exam of lung airway using an endoscope | – | 16 | 30 | 48 | – | – |
| Emergent insertion of breathing tube into windpipe using an endoscope | – | 26 | 30 | 22 | 12 | – |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | – | 30 | 28 | – | – | 16 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | – | – | – | – | 32 | 25 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,010 Original Medicare patients in 2024. Average age 75 · Under 65 13% · 85 and older 21% · Women 50% · Also on Medicaid 65% · Health risk score 3.64. Sicker patients than 9 in 10 peers; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75% · Diabetes 64% · Heart failure 60% · Chronic kidney disease 57% · Coronary heart disease 51% · COPD 49% · Atrial fibrillation 42% · Depression 34% · Dementia 31% · Stroke 28% · Cancer 18%.
The office billed $1,049,057, Medicare allowed $643,783 and paid $496,962; for 6,187 services of 49 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,010 | 6,187 | 75 | 3.64 | $1,049,057 | $496,962 |
| 2023 | 1,020 | 5,963 | 75 | 3.59 | $1,217,850 | $527,029 |
| 2022 | 934 | 5,917 | 74 | 3.45 | $1,206,854 | $527,392 |
| 2021 | 941 | 5,110 | 73 | 3.41 | $838,508 | $480,508 |
| 2020 | 925 | 4,668 | 74 | 3.68 | $737,241 | $484,146 |
| 2019 | 346 | 1,873 | 71 | 3.92 | $264,039 | $165,045 |
| 2018 | 42 | 68 | 68 | 1.98 | $9,596 | $6,031 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 25 services
| Critical care, first 30-74 minutes | 296 | $153,078 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 526 | $127,059 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 529 | $102,118 | $98 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 322 | $36,738 | $106 |
| Return visit (30+ min) | 103 | $24,553 | $104 |
| Advance care planning, first 30 minutes | 251 | $16,633 | $62 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 60 | $15,629 | $89 |
| New patient visit (45+ min) | 43 | $5,053 | $118 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $4,375 | $141 |
| Test to examine how well the lungs exchange gases | 69 | $3,550 | $50 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 31 | $3,496 | $109 |
| Test to determine lung volumes using sensors | 69 | $3,342 | $47 |
| Long return visit (40+ min) | 15 | $3,227 | $147 |
| Short return visit (20+ min) | 27 | $2,538 | $75 |
| Evaluation of use of breathing device | 72 | $2,357 | $14 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 69 | $2,303 | $32 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 17 | $2,124 | $112 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 34 | $2,065 | $56 |
| Test for exercise-induced lung stress | 59 | $1,740 | $28 |
| Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | 71 | $1,452 | $20 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 12 | $1,365 | $114 |
| Return visit (30+ min) | 12 | $1,324 | $70 |
| Test to measure expiratory airflow and volume | 39 | $1,191 | $24 |
| Test to measure largest amount of air breathed in an out | 68 | $939 | $13 |
| Hemoglobin measurement | 52 | $265 | $5 |
2022: 24 services
| Critical care, first 30-74 minutes | 294 | $192,899 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 548 | $142,655 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 443 | $84,263 | $85 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 350 | $40,982 | $112 |
| Return visit (30+ min) | 62 | $14,471 | $105 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 42 | $8,510 | $58 |
| Diagnostic exam of lung airway using an endoscope | 45 | $5,311 | $111 |
| Test to examine how well the lungs exchange gases | 79 | $3,994 | $49 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,775 | $164 |
| Test to determine lung volumes using sensors | 79 | $3,687 | $46 |
| New patient visit (45+ min) | 23 | $3,194 | $139 |
| Return visit (30+ min) | 22 | $3,017 | $79 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 79 | $2,625 | $32 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 21 | $2,582 | $117 |
| Evaluation of use of breathing device | 59 | $1,720 | $15 |
| Short return visit (20+ min) | 18 | $1,600 | $73 |
| New patient visit (45+ min) | 14 | $1,499 | $107 |
| Test for exercise-induced lung stress | 45 | $1,226 | $27 |
| Advance care planning, first 30 minutes | 14 | $963 | $64 |
| Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | 47 | $915 | $19 |
| Short return visit (20+ min) | 13 | $800 | $44 |
| Test to measure largest amount of air breathed in an out | 43 | $568 | $13 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 12 | $465 | $39 |
| Hemoglobin measurement | 18 | $89 | $5 |
2021: 19 services
| Critical care, first 30-74 minutes | 290 | $195,357 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 611 | $168,561 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 286 | $43,719 | $87 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 207 | $24,223 | $112 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $12,387 | $157 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 29 | $3,582 | $119 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 37 | $3,566 | $59 |
| Return visit (30+ min) | 31 | $3,559 | $76 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 18 | $3,463 | $75 |
| Diagnostic exam of lung airway using an endoscope | 27 | $3,289 | $110 |
| Return visit (30+ min) | 21 | $2,510 | $109 |
| New patient visit (45+ min) | 20 | $2,229 | $111 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 28 | $1,991 | $71 |
| Advance care planning, first 30 minutes | 20 | $1,313 | $66 |
| Test to examine how well the lungs exchange gases | 15 | $902 | $53 |
| Test to determine lung volumes using sensors | 15 | $822 | $48 |
| Short return visit (20+ min) | 11 | $729 | $52 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 15 | $699 | $41 |
| Ultrasonic guidance for blood vessel access | 20 | $233 | $12 |
2020: 14 services
| Critical care, first 30-74 minutes | 330 | $227,506 | $190 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 613 | $131,955 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 321 | $60,308 | $88 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 218 | $26,135 | $114 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 89 | $15,634 | $172 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 26 | $3,211 | $124 |
| New patient visit (45+ min) | 29 | $2,797 | $96 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 26 | $2,211 | $74 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 30 | $1,888 | $59 |
| Diagnostic exam of lung airway using an endoscope | 16 | $1,819 | $114 |
| Advance care planning, first 30 minutes | 23 | $1,617 | $67 |
| Short return visit (20+ min) | 25 | $1,521 | $43 |
| Return visit (30+ min) | 13 | $1,038 | $65 |
| Ultrasonic guidance for blood vessel access | 23 | $336 | $12 |
2019: 8 services
| Critical care, first 30-74 minutes | 78 | $46,331 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 151 | $37,347 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 125 | $22,368 | $58 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 97 | $20,702 | $55 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 60 | $14,917 | $71 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 52 | $7,189 | $131 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 60 | $6,788 | $111 |
| Initial nursing facility care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $811 | $74 |
2018: 1 service
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,158 | $105 |
Medicaid work
$121,715 in 2024
Medicaid paid $121,715 for 3,808 billed services this clinician did in 2024, up to 75 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 993 | $61,417 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 1,049 | $24,981 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 1,332 | $24,626 |
| Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate | 167 | $3,951 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 113 | $3,100 |
| Return visit (30+ min) | 44 | $1,779 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 23 | $1,194 |
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 46 | $356 |
| Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device | 41 | $312 |
| 2024 | 3,808 | 9 | 75 | $121,715 |
| 2023 | 4,514 | 10 | 75 | $145,778 |
| 2022 | 4,425 | 5 | 71 | $160,643 |
| 2021 | 3,823 | 7 | 101 | $170,737 |
| 2020 | 3,097 | 7 | 84 | $157,047 |
| 2019 | 2,023 | 7 | 58 | $93,021 |
| 2018 | 37 | 2 | 12 | $1,041 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 915 | $58,805 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 1,831 | $34,250 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 1,099 | $33,096 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 259 | $10,488 |
| Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate | 122 | $3,943 |
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 152 | $3,423 |
| Return visit (30+ min) | 52 | $933 |
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 32 | $519 |
| Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device | 39 | $184 |
| New patient visit (45+ min) | 13 | $138 |
2022
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 940 | $67,205 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 2,110 | $48,507 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 951 | $30,041 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 275 | $12,150 |
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 149 | $2,739 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 1,026 | $90,667 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 2,174 | $57,221 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 467 | $16,103 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 91 | $3,719 |
| 1ST HOSP IP/OBS HIGH 75 | 20 | $1,549 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 18 | $1,059 |
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 27 | $419 |
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 1,135 | $100,883 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 1,418 | $35,670 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 388 | $12,865 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 72 | $3,559 |
| 1ST HOSP IP/OBS HIGH 75 | 46 | $2,695 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 20 | $1,118 |
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 18 | $257 |
2019
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 783 | $34,912 |
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 869 | $31,018 |
| INITIAL NURSING FACILITY CARE HI MDM 50 MINUTES | 216 | $20,347 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 41 | $3,287 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 63 | $1,914 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 39 | $1,048 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 12 | $496 |
2018
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 19 | $544 |
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 18 | $497 |
Drugs they prescribed that Part D paid
$315,962
Pharmacies billed $315,962 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 914) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.
0 generic and 467 brand-name prescriptions · $315,962 in drug cost · 60 antibiotic prescriptions to 44 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 138 | $87,822 | $636 |
| Breo Ellipta | 44 | $17,287 | $393 |
| Breztri Aerosphere | 24 | $14,824 | $618 |
| Advair Hfa | 32 | $10,930 | $342 |
| Spiriva Respimat | 18 | $9,257 | $514 |
See all 19 drugs
| Trelegy Ellipta | 138 | $87,822 | $636 |
| Breo Ellipta | 44 | $17,287 | $393 |
| Breztri Aerosphere | 24 | $14,824 | $618 |
| Advair Hfa | 32 | $10,930 | $342 |
| Spiriva Respimat | 18 | $9,257 | $514 |
| Anoro Ellipta | 12 | $5,447 | $454 |
| Tudorza Pressair | 12 | $5,216 | $435 |
| Albuterol Sulfate Hfa | 133 | $5,175 | $39 |
| Wixela Inhub | 40 | $4,816 | $120 |
| Symbicort | 12 | $4,747 | $396 |
| Fluticasone-Salmeterol | 42 | $4,543 | $108 |
| Breyna | 14 | $2,377 | $170 |
| Ipratropium-Albuterol | 30 | $837 | $28 |
| Ventolin Hfa | 15 | $830 | $55 |
| Fluticasone Propionate | 35 | $351 | $10 |
| Montelukast | 56 | $326 | $6 |
| Methylprednisolone | 35 | $153 | $4 |
| Azithromycin | 44 | $145 | $3 |
| Prednisone | 35 | $94 | $3 |
Year by year
| 2024 | 914 | 199 | 0% (0) | 51% | $315,962 |
| 2023 | 676 | 155 | 0% (0) | 55% | $275,425 |
| 2022 | 516 | 109 | 0% (0) | 52% | $141,618 |
| 2021 | 387 | 96 | 0% (0) | 52% | $84,253 |
| 2020 | 88 | 21 | 0% (0) | 50% | $20,379 |
| 2019 | 321 | 61 | 13% (40) | 22% | $21,497 |
| 2018 | 83 | 18 | 0% (0) | 31% | $52,853 |
| 2017 | 68 | 21 | None | None | $5,319 |
| 2016 | 125 | 23 | None | 12% | $10,260 |
| 2015 | 219 | 41 | None | None | $19,071 |
| 2014 | 174 | 43 | None | None | $5,637 |
| 2013 | 90 | 27 | None | None | $967 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Trelegy Ellipta | 72 | $57,121 | $793 |
| Ozempic | 14 | $21,762 | $1,554 |
| Symbicort | 45 | $21,124 | $469 |
| Advair Diskus | 36 | $19,243 | $535 |
| Breo Ellipta | 22 | $12,418 | $564 |
| Breztri Aerosphere | 16 | $10,407 | $650 |
| Spiriva Respimat | 16 | $9,055 | $566 |
| Fluticasone-Salmeterol | 17 | $6,322 | $372 |
| Wixela Inhub | 15 | $4,831 | $322 |
| Albuterol Sulfate Hfa | 68 | $2,721 | $40 |
| Ventolin Hfa | 26 | $1,699 | $65 |
| Montelukast | 48 | $606 | $13 |
| Fluticasone Propionate | 39 | $558 | $14 |
| Ipratropium | 19 | $553 | $29 |
| Omeprazole | 25 | $420 | $17 |
| Methylprednisolone | 28 | $239 | $9 |
| Prednisone | 34 | $137 | $4 |
| Azithromycin | 20 | $85 | $4 |
2022: 12 drugs
| Trelegy Ellipta | 76 | $52,851 | $695 |
| Breo Ellipta | 42 | $18,039 | $430 |
| Advair Diskus | 25 | $14,512 | $580 |
| Symbicort | 28 | $12,663 | $452 |
| Eliquis | 14 | $7,987 | $571 |
| Albuterol Sulfate Hfa | 79 | $3,607 | $46 |
| Montelukast | 70 | $1,044 | $15 |
| Omeprazole | 21 | $184 | $9 |
| Fluticasone Propionate | 18 | $176 | $10 |
| Prednisone | 24 | $101 | $4 |
| Methylprednisolone | 12 | $83 | $7 |
| Azithromycin | 11 | $64 | $6 |
2021: 10 drugs
| Trelegy Ellipta | 53 | $35,182 | $664 |
| Symbicort | 28 | $12,791 | $457 |
| Breo Ellipta | 14 | $5,454 | $390 |
| Wixela Inhub | 24 | $5,141 | $214 |
| Albuterol Sulfate Hfa | 58 | $2,479 | $43 |
| Fluticasone-Salmeterol | 13 | $2,311 | $178 |
| Ventolin Hfa | 16 | $938 | $59 |
| Montelukast | 43 | $334 | $8 |
| Fluticasone Propionate | 15 | $219 | $15 |
| Prednisone | 26 | $102 | $4 |
2020: 2 drugs
| Symbicort | 18 | $12,038 | $669 |
| Prednisone | 11 | $41 | $4 |
2019: 5 drugs
| Oxycodone | 31 | $648 | $21 |
| Furosemide | 26 | $246 | $9 |
| Atorvastatin | 14 | $202 | $14 |
| Warfarin | 11 | $89 | $8 |
| Metoprolol | 12 | $72 | $6 |
2018: 1 drug
| Fluconazole | 16 | $1,373 | $86 |
2016: 4 drugs
| Atorvastatin | 12 | $256 | $21 |
| Omeprazole | 14 | $63 | $5 |
| Amitriptyline | 12 | $63 | $5 |
| Hydrochlorothiazide | 19 | $38 | $2 |
2015: 3 drugs
| Gabapentin | 14 | $544 | $39 |
| Atorvastatin | 18 | $357 | $20 |
| Hydrochlorothiazide | 11 | $31 | $3 |
2014: 3 drugs
| Atorvastatin | 13 | $230 | $18 |
| Lisinopril | 14 | $137 | $10 |
| Amlodipine Besylate | 13 | $76 | $6 |
2013: 1 drug
| Metformin | 13 | $93 | $7 |
Money from drug and device companies
$914 in 2025
| 2025 | 13 | 49 | None | $914 |
| 2024 | 9 | 30 | None | $471 |
| 2023 | 5 | 28 | None | $610 |
| 2022 | 5 | 43 | None | $522 |
| 2021 | 5 | 10 | None | $191 |
| 2020 | 2 | 3 | None | $137 |
| 2019 | 9 | 23 | None | $1,547 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Trelegy Ellipta | $302 | 24 payments
|
| Regeneron Healthcare Solutions | Dupixent | $151 | 6 payments
|
| Genzyme | Dupixent | $124 | 4 payments
|
| Verona Pharma | Ohtuvayre | $56 | 2 payments
|
| Insmed | Arikayce | $53 | 2 payments
|
| Baxter Healthcare | Hillrom - Monarch Airway Clearance System | $41 | 2 payments
|
See all 48 published payments
| GlaxoSmithKline | Meals · 2025-12-11 | Nucala | $9 |
| Regeneron Healthcare Solutions | Meals · 2025-12-09 | Dupixent | $21 |
| Verona Pharma | Meals · 2025-11-25 | Ohtuvayre | $32 |
| GlaxoSmithKline | Meals · 2025-11-20 | Nucala | $5 |
| GlaxoSmithKline | Meals · 2025-11-20 | Nucala | $5 |
| Baxter Healthcare | Meals · 2025-11-15 | Hillrom - Monarch Airway Clearance System | $23 |
| Genzyme | Meals · 2025-11-10 | Dupixent | $26 |
| Genzyme | Meals · 2025-11-05 | Dupixent | $24 |
| GlaxoSmithKline | Meals · 2025-11-04 | Trelegy Ellipta | $25 |
| GlaxoSmithKline | Meals · 2025-11-04 | Trelegy Ellipta | $11 |
| Regeneron Healthcare Solutions | Meals · 2025-10-29 | Dupixent | $31 |
| Regeneron Healthcare Solutions | Meals · 2025-10-29 | Dupixent | $11 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-24 | Jascayd | $19 |
| Verona Pharma | Meals · 2025-10-21 | Ohtuvayre | $24 |
| Medtronic | Meals · 2025-10-16 | Progrip | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-10-14 | Dupixent | $37 |
| GlaxoSmithKline | Meals · 2025-10-09 | Trelegy Ellipta | $7 |
| GlaxoSmithKline | Meals · 2025-10-09 | Trelegy Ellipta | $1 |
| GlaxoSmithKline | Meals · 2025-10-08 | Nucala | $8 |
| Regeneron Healthcare Solutions | Meals · 2025-09-16 | Dupixent | $15 |
| GlaxoSmithKline | Meals · 2025-09-12 | Nucala | $6 |
| Genzyme | Meals · 2025-09-04 | Dupixent | $33 |
| GlaxoSmithKline | Meals · 2025-09-03 | Nucala | $24 |
| GlaxoSmithKline | Meals · 2025-08-26 | Trelegy Ellipta | $7 |
| Insmed | Meals · 2025-08-18 | Arikayce | $22 |
| Insmed | Meals · 2025-08-08 | Arikayce | $30 |
| Genzyme | Meals · 2025-08-06 | Dupixent | $41 |
| GlaxoSmithKline | Meals · 2025-08-05 | Nucala | $13 |
| Regeneron Healthcare Solutions | Meals · 2025-07-17 | Dupixent | $36 |
| GlaxoSmithKline | Meals · 2025-07-16 | Nucala | $5 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-07-10 | Ofev | $18 |
| GlaxoSmithKline | Meals · 2025-06-19 | Trelegy Ellipta | $7 |
| ANI Pharmaceuticals | Meals · 2025-06-19 | Purified Cortrophin Gel | $33 |
| GlaxoSmithKline | Meals · 2025-06-18 | Nucala | $0 |
| GlaxoSmithKline | Meals · 2025-06-18 | Nucala | $17 |
| GlaxoSmithKline | Meals · 2025-06-12 | Nucala | $25 |
| GlaxoSmithKline | Meals · 2025-05-20 | Trelegy Ellipta | $34 |
| GlaxoSmithKline | Meals · 2025-05-09 | Nucala | $24 |
| Baxter Healthcare | Meals · 2025-05-02 | Hillrom - Volara System | $18 |
| Lilly USA | Meals · 2025-05-01 | Mounjaro | $16 |
| GlaxoSmithKline | Meals · 2025-04-17 | Nucala | $5 |
| Amgen | Meals · 2025-04-17 | Tezspire | $25 |
| Merck Sharp & Dohme | Meals · 2025-04-15 | Winrevair | $29 |
| GlaxoSmithKline | Meals · 2025-02-25 | Trelegy Ellipta | $23 |
| GlaxoSmithKline | Meals · 2025-02-21 | Trelegy Ellipta | $25 |
| United Therapeutics | Meals · 2025-02-05 | Tyvaso | $29 |
| GlaxoSmithKline | Meals · 2025-01-28 | Trelegy Ellipta | $7 |
| GlaxoSmithKline | Meals · 2025-01-02 | Trelegy Ellipta | $8 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $471
| GlaxoSmithKline | Trelegy Ellipta | $241 | 19 payments
|
| Regeneron Healthcare Solutions | Dupixent | $63 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $52 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Tezspire | $30 | 1 payment
|
| Insmed | Arikayce | $23 | 1 payment
|
| Abbott Laboratories | Proclaim | $22 | 1 payment
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $18 | 1 payment
|
| Philips North America | (8874) Incourage | $15 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $6 | 1 payment
|
2023: $610
| AstraZeneca Pharmaceuticals LP | Breztri | $327 | 6 payments
|
| Genzyme | Dupixent | $166 | 7 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $66 | 3 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $35 | 2 payments
|
| Philips Electronics North America | (9061) Src Sol Space | $16 | 1 payment
|
2022: $522
| Regeneron Healthcare Solutions | Dupixent | $214 | 10 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $125 | 11 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $123 | 3 payments
|
| Gilead Sciences | None | $32 | 1 payment
|
| Shionogi | Fetroja | $28 | 1 payment
|
2021: $191
| Regeneron Healthcare Solutions | Dupixent | $49 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $45 | 3 payments
|
| Shionogi | Fetroja | $39 | 2 payments
|
| GlaxoSmithKline | Nucala | $32 | 2 payments
|
| Teva Pharmaceuticals USA | Airduo Digihaler | $26 | 1 payment
|
2020: $137
| Portola Pharmaceuticals | Andexxa | $109 | 1 payment
|
| GlaxoSmithKline | Nucala | $28 | 2 payments
|
2019: $1,547
| Olympus Corporation of the Americas | Olympus Ebus Bronchoscopes | $1,121 | 10 payments
|
| Paratek Pharmaceuticals | Nuzyra | $125 | 1 payment
|
| United Therapeutics | Orenitram | $85 | 1 payment
|
| Philips Electronics North America | Incourage | $67 | 3 payments
|
| Actelion Pharmaceuticals US | Opsumit | $53 | 2 payments
|
| GlaxoSmithKline | Nucala | $47 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $27 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $12 | 1 payment
|
| Shire North American Group | Glassia | $11 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 58.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1669810123
- Licence
- CA 20A16993
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Federal specialty code 207RC0200X (207RC0200X)
- Mailing address
- 12223 Highland Ave # 106-605, Rancho Cucamonga, CA, 91739
- NPI first listed
- 2013-06-06
- NPI last updated
- 2026-08-11
- NPI record certified
- 2026-08-11
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1111 E Mcdowell Rd, Phoenix, AZ, 85006 · 500 N Euclid Ave, Upland, CA, 91786